SOLIFENACIN SUCCIATE

SOLIFENACIN SUCCIATE was reported 1914 times

SOLIFENACIN SUCCIATE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 OSMOPHOBIA 3 0.1875
1 AMYLOIDOMA 3 0.1579
2 PHANTOSMIA 4 0.1290
3 CEREBRAL HYPOPERFUSION 53 0.1137
4 STOMA SITE DERMATITIS 3 0.0909
5 BINOCULAR EYE MOVEMENT DISORDER 26 0.0903
6 STOMA SITE CANDIDA 2 0.0741
7 CEREBELLAR STROKE 26 0.0665
8 LACK OF INFUSION SITE ROTATION 3 0.0625
9 ANTICHOLINERGIC EFFECT 4 0.0533
10 ANTIACETYLCHOLINE RECEPTOR ANTIBODY POSITIVE 3 0.0400
11 RADIATION INFLAMMATION 3 0.0375
12 SPERM CONCENTRATION ZERO 3 0.0357
13 BLOOD LACTIC ACID ABNORMAL 4 0.0357
14 ENTEROCOLITIS BACTERIAL 7 0.0254
15 BULBOSPINAL MUSCULAR ATROPHY CONGENITAL 1 0.0233
16 OSCILLOPSIA 6 0.0232
17 BLOOD PRESSURE AMBULATORY INCREASED 1 0.0217
18 ACROPHOBIA 1 0.0167
19 CEREBELLAR ISCHAEMIA 3 0.0161
20 FEAR OF EATING 5 0.0161
21 PHANTOM LIMB SYNDROME 3 0.0159
22 POVERTY OF SPEECH 6 0.0153
23 ADRENAL GLAND CANCER METASTATIC 1 0.0147
24 HYPOTONIC URINARY BLADDER 2 0.0147
25 HYPORESPONSIVE TO STIMULI 16 0.0136
26 SUBACUTE HEPATIC FAILURE 2 0.0134
27 BLADDER SPHINCTER ATONY 2 0.0129
28 EXCESSIVE CERUMEN PRODUCTION 8 0.0129
29 GASTROENTERITIS STAPHYLOCOCCAL 2 0.0127
30 STOMA SITE ABSCESS 3 0.0123
31 BLOOD COPPER DECREASED 1 0.0122
32 BLADDER OUTLET OBSTRUCTION 2 0.0121
33 GENITAL ULCERATION 9 0.0117
34 ENCEPHALOMYELITIS 3 0.0110
35 DEVICE COLOUR ISSUE 4 0.0099
36 PENILE BLISTER 2 0.0094
37 DUPLICATE THERAPY ERROR 3 0.0093
38 SLOW RESPONSE TO STIMULI 12 0.0093
39 CEREBRAL AMYLOID ANGIOPATHY 3 0.0091
40 VASCULITIC RASH 7 0.0091
41 SALIVA DISCOLOURATION 3 0.0090
42 BLOOD VISCOSITY INCREASED 5 0.0083
43 CATHETER SITE DISCOLOURATION 1 0.0082
44 BULLOUS LUNG DISEASE 1 0.0080
45 STOMA SITE HYPERGRANULATION 5 0.0079
46 STOMA SITE EXTRAVASATION 3 0.0078
47 BLOOD LACTIC ACID 1 0.0078
48 ADMINISTRATION SITE IRRITATION 1 0.0071
49 ATTENTION-SEEKING BEHAVIOUR 1 0.0064
50 ACID FAST BACILLI INFECTION 1 0.0062
51 STOMA SITE PAIN 9 0.0061
52 GENITAL PAIN 9 0.0061
53 HEAT ILLNESS 4 0.0059
54 DIAPHRAGMALGIA 2 0.0058
55 BLOOD ZINC DECREASED 1 0.0055
56 PENILE ERYTHEMA 2 0.0053
57 CATHETER SITE NODULE 1 0.0052
58 LOCALISED INTRAABDOMINAL FLUID COLLECTION 2 0.0044
59 ACUTE MOTOR-SENSORY AXONAL NEUROPATHY 1 0.0043
60 STOMA SITE ERYTHEMA 8 0.0043
61 VAGINAL DISORDER 4 0.0042
62 PRIMARY PROGRESSIVE MULTIPLE SCLEROSIS 2 0.0041
63 DUODENAL STENOSIS 2 0.0041
64 STOMA SITE INFLAMMATION 3 0.0040
65 ON AND OFF PHENOMENON 22 0.0040
66 FRUSTRATION TOLERANCE DECREASED 30 0.0037
67 BLADDER DILATATION 4 0.0037
68 MEDICAL DEVICE SITE PAIN 2 0.0036
69 BLADDER TAMPONADE 1 0.0033
70 BLADDER DISCOMFORT 4 0.0032
71 INFUSION SITE IRRITATION 4 0.0031
72 CEREBRAL SMALL VESSEL ISCHAEMIC DISEASE 2 0.0030
73 DEFAECATION DISORDER 2 0.0030
74 MICTURITION URGENCY 33 0.0029
75 DRUG-DISEASE INTERACTION 2 0.0027
76 NOCTURIA 32 0.0026
77 ANOSOGNOSIA 2 0.0026
78 ADRENAL GLAND CANCER 1 0.0026
79 BLISTER INFECTED 2 0.0026
80 RETROGRADE EJACULATION 2 0.0025
81 EYELID PAIN 5 0.0025
82 ANHIDROSIS 1 0.0025
83 PERIORBITAL PAIN 2 0.0024
84 STOMA SITE INFECTION 3 0.0023
85 THALAMUS HAEMORRHAGE 2 0.0023
86 ANTIPSYCHOTIC DRUG LEVEL ABOVE THERAPEUTIC 2 0.0022
87 STOMA SITE DISCHARGE 6 0.0022
88 BONE CONTUSION 2 0.0022
89 BEZOAR 3 0.0022
90 CARDIAC PACEMAKER REPLACEMENT 1 0.0022
91 BLOOD PHOSPHORUS ABNORMAL 1 0.0021
92 INTUSSUSCEPTION 2 0.0021
93 CHRONIC INFLAMMATORY DEMYELINATING POLYRADICULONEUROPATHY 3 0.0021
94 HYPERTONIC BLADDER 6 0.0021
95 PYURIA 2 0.0020
96 STOMA SITE HAEMORRHAGE 3 0.0019
97 BLADDER OBSTRUCTION 1 0.0019
98 COGWHEEL RIGIDITY 2 0.0019
99 EYE CONTUSION 4 0.0019
100 FEELING COLD 52 0.0019
101 STRESS URINARY INCONTINENCE 2 0.0019
102 BODY FAT DISORDER 1 0.0018
103 PRODUCT SELECTION ERROR 2 0.0018
104 GASTRIC POLYPS 4 0.0018
105 ANTERIOR CHAMBER INFLAMMATION 1 0.0017
106 FOOD POISONING 9 0.0017
107 GASTROINTESTINAL OBSTRUCTION 4 0.0017
108 EYE OEDEMA 4 0.0016
109 ACUTE PSYCHOSIS 4 0.0016
110 CARDIAC DYSFUNCTION 6 0.0016
111 FRACTURED SACRUM 2 0.0016
112 BLADDER SPASM 3 0.0016
113 GENERAL SYMPTOM 12 0.0016
114 ARTERITIS 1 0.0016
115 BLADDER IRRITATION 1 0.0016
116 OCULAR HYPERTENSION 3 0.0015
117 CEREBRAL ATROPHY 6 0.0015
118 FAECALOMA 8 0.0015
119 OLIGURIA 9 0.0014
120 RHONCHI 2 0.0014
121 DEVICE CONNECTION ISSUE 3 0.0014
122 ATYPICAL MYCOBACTERIAL INFECTION 2 0.0014
123 ALPHA 1 FOETOPROTEIN INCREASED 1 0.0014
124 CARDIAC SEPTAL DEFECT 1 0.0014
125 INFUSION SITE BRUISING 3 0.0014
126 DIPLOPIA 36 0.0014
127 CUTANEOUS VASCULITIS 5 0.0014
128 BILIARY DILATATION 2 0.0014
129 PSYCHIATRIC SYMPTOM 10 0.0014
130 HEART VALVE REPLACEMENT 2 0.0014
131 IMPETIGO 2 0.0013
132 ANGIOPLASTY 2 0.0013
133 ANAL INCONTINENCE 12 0.0013
134 BRONCHITIS BACTERIAL 1 0.0013
135 URINARY INCONTINENCE 39 0.0013
136 BLOOD ALCOHOL INCREASED 1 0.0013
137 AORTIC DISORDER 1 0.0013
138 URINARY TRACT OBSTRUCTION 3 0.0013
139 ANTICHOLINERGIC SYNDROME 2 0.0013
140 CARTILAGE ATROPHY 1 0.0012
141 PRESYNCOPE 30 0.0012
142 POSTURE ABNORMAL 4 0.0012
143 BRADYARRHYTHMIA 2 0.0012
144 QUADRIPARESIS 2 0.0012
145 PERIPHERAL SENSORY NEUROPATHY 7 0.0012
146 NEURALGIA 29 0.0012
147 CONTRAINDICATED PRODUCT PRESCRIBED 2 0.0012
148 ANGLE CLOSURE GLAUCOMA 3 0.0012
149 ABSCESS DRAINAGE 1 0.0012
150 AXONAL NEUROPATHY 1 0.0011
151 SPEECH DISORDER 60 0.0011
152 ARTERIAL STENOSIS 1 0.0011
153 INFUSION SITE DISCHARGE 2 0.0011
154 ADRENOCORTICOTROPIC HORMONE DEFICIENCY 1 0.0011
155 DIZZINESS POSTURAL 11 0.0011
156 KYPHOSIS 2 0.0011
157 URINARY RETENTION 36 0.0011
158 CATHETER PLACEMENT 2 0.0011
159 TUNNEL VISION 2 0.0011
160 DYSPNOEA AT REST 3 0.0010
161 BLADDER CATHETERISATION 1 0.0010
162 PULMONARY PAIN 3 0.0010
163 TOOTH DISCOLOURATION 3 0.0010
164 ATAXIA 12 0.0010
165 FEMORAL NECK FRACTURE 5 0.0010
166 BLADDER DYSFUNCTION 1 0.0010
167 CONCOMITANT DISEASE AGGRAVATED 6 0.0010
168 CAROTID ARTERIOSCLEROSIS 1 0.0010
169 SLEEP DEFICIT 2 0.0009
170 BONE DEMINERALISATION 1 0.0009
171 VULVOVAGINAL DRYNESS 3 0.0009
172 PEMPHIGOID 7 0.0009
173 LANGUAGE DISORDER 2 0.0009
174 INCORRECT DISPOSAL OF PRODUCT 3 0.0009
175 HEPATITIS ACUTE 6 0.0009
176 CEREBELLAR SYNDROME 2 0.0009
177 ELECTROCARDIOGRAM T WAVE INVERSION 2 0.0009
178 TONGUE BLISTERING 2 0.0009
179 BLOODY DISCHARGE 1 0.0009
180 PUSTULAR PSORIASIS 3 0.0009
181 CARBON DIOXIDE DECREASED 1 0.0009
182 ACUTE PRERENAL FAILURE 1 0.0009
183 BLADDER OPERATION 1 0.0009
184 DYSARTHRIA 32 0.0008
185 PULMONARY INFARCTION 2 0.0008
186 URINARY HESITATION 2 0.0008
187 BLEEDING TIME PROLONGED 1 0.0008
188 DEVICE KINK 3 0.0008
189 GASTROINTESTINAL PAIN 9 0.0008
190 DIABETIC NEUROPATHY 4 0.0008
191 INFLAMMATORY MARKER INCREASED 4 0.0008
192 HEART INJURY 2 0.0008
193 ALLERGY TO CHEMICALS 1 0.0008
194 INFREQUENT BOWEL MOVEMENTS 2 0.0008
195 AMPUTATION 1 0.0008
196 GASTROINTESTINAL TUBE INSERTION 2 0.0008
197 THROAT CLEARING 3 0.0008
198 INFUSION SITE SWELLING 5 0.0008
199 PARKINSON'S DISEASE 2 0.0008
200 THIRST 14 0.0008
201 BLOOD CREATINE PHOSPHOKINASE MB INCREASED 1 0.0008
202 SEASONAL ALLERGY 11 0.0008
203 DRY MOUTH 63 0.0008
204 BENIGN PROSTATIC HYPERPLASIA 4 0.0008
205 PANIC DISORDER 3 0.0008
206 INCOHERENT 5 0.0008
207 BILIARY OBSTRUCTION 1 0.0008
208 FAECES HARD 3 0.0008
209 PNEUMONIA BACTERIAL 7 0.0008
210 DYSURIA 28 0.0008
211 POLYDIPSIA 3 0.0008
212 SERUM FERRITIN INCREASED 4 0.0008
213 ABNORMAL SLEEP-RELATED EVENT 1 0.0008
214 ACROCHORDON 1 0.0008
215 MYASTHENIA GRAVIS 6 0.0007
216 DEMYELINATION 3 0.0007
217 POLLAKIURIA 30 0.0007
218 CARDIOVERSION 1 0.0007
219 DRUG TOLERANCE DECREASED 2 0.0007
220 BODY TEMPERATURE DECREASED 7 0.0007
221 BLADDER DISORDER 7 0.0007
222 AUDITORY DISORDER 1 0.0007
223 PURULENT DISCHARGE 3 0.0007
224 HYPERTONIA 4 0.0007
225 BLOOD SODIUM DECREASED 13 0.0007
226 URINE OUTPUT DECREASED 6 0.0007
227 BALANCE DISORDER 59 0.0007
228 ANKLE OPERATION 1 0.0007
229 APRAXIA 1 0.0007
230 BLOOD PRESSURE SYSTOLIC INCREASED 13 0.0007
231 HYPERCAPNIA 2 0.0007
232 CEREBROVASCULAR DISORDER 2 0.0007
233 DYSCHEZIA 2 0.0007
234 BUNDLE BRANCH BLOCK RIGHT 3 0.0007
235 MASTICATION DISORDER 2 0.0007
236 INTRACARDIAC THROMBUS 2 0.0007
237 BACTERIAL VAGINOSIS 1 0.0006
238 MULTIPLE ALLERGIES 5 0.0006
239 SARCOIDOSIS 3 0.0006
240 LOSS OF THERAPEUTIC RESPONSE 2 0.0006
241 ORAL PAIN 14 0.0006
242 VULVOVAGINAL PAIN 3 0.0006
243 ANTIPHOSPHOLIPID SYNDROME 1 0.0006
244 LIVER ABSCESS 2 0.0006
245 DYSPHONIA 36 0.0006
246 DEMENTIA 17 0.0006
247 ARTHROPOD STING 1 0.0006
248 ATRIOVENTRICULAR BLOCK COMPLETE 4 0.0006
249 POTENTIATING DRUG INTERACTION 2 0.0006
250 BK VIRUS INFECTION 2 0.0006
251 BILIARY DYSKINESIA 1 0.0006
252 MOTOR DYSFUNCTION 6 0.0006
253 BLADDER NEOPLASM 1 0.0006
254 BLOOD CREATININE ABNORMAL 2 0.0006
255 EYE DISCHARGE 6 0.0006
256 MICTURITION DISORDER 2 0.0006
257 BLOOD LACTIC ACID INCREASED 3 0.0006
258 RENAL PAIN 6 0.0006
259 MOUTH HAEMORRHAGE 4 0.0005
260 CALCIPHYLAXIS 1 0.0005
261 FREEZING PHENOMENON 2 0.0005
262 FEELING DRUNK 4 0.0005
263 ANGIOPATHY 3 0.0005
264 PULMONARY ALVEOLAR HAEMORRHAGE 3 0.0005
265 HYPONATRAEMIA 30 0.0005
266 HYPERTHERMIA 4 0.0005
267 OESOPHAGEAL ULCER 2 0.0005
268 HAEMOLYSIS 4 0.0005
269 CONCUSSION 4 0.0005
270 BRONCHOPULMONARY ASPERGILLOSIS 4 0.0005
271 EYE PAIN 29 0.0005
272 PROSTATOMEGALY 2 0.0005
273 PNEUMONIA FUNGAL 2 0.0005
274 LIGAMENT SPRAIN 5 0.0005
275 BACTERAEMIA 6 0.0005
276 ULCER 8 0.0005
277 CREATININE RENAL CLEARANCE DECREASED 2 0.0005
278 MIOSIS 4 0.0005
279 TOXIC SKIN ERUPTION 5 0.0005
280 ORGAN FAILURE 2 0.0005
281 ENURESIS 2 0.0005
282 POLYURIA 4 0.0005
283 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 5 0.0005
284 EXTRAVASATION 2 0.0005
285 EUGLYCAEMIC DIABETIC KETOACIDOSIS 2 0.0005
286 CHOLANGITIS 3 0.0005
287 TUBULOINTERSTITIAL NEPHRITIS 9 0.0005
288 SELF-INJURIOUS IDEATION 2 0.0005
289 HALLUCINATIONS, MIXED 2 0.0005
290 BUNDLE BRANCH BLOCK LEFT 2 0.0005
291 FOREIGN BODY SENSATION IN EYES 3 0.0005
292 HORDEOLUM 2 0.0005
293 ATRIOVENTRICULAR BLOCK FIRST DEGREE 2 0.0005
294 HAEMORRHOIDS 9 0.0005
295 DIVERTICULUM INTESTINAL 2 0.0005
296 HAEMORRHAGIC ANAEMIA 2 0.0005
297 WALKING AID USER 3 0.0005
298 GAIT DISTURBANCE 86 0.0004
299 HYPOTENSION 90 0.0004
300 BACTERIAL TEST POSITIVE 1 0.0004
301 CALCINOSIS 1 0.0004
302 COLITIS ISCHAEMIC 3 0.0004
303 BLOOD LOSS ANAEMIA 1 0.0004
304 CONSTIPATION 96 0.0004
305 EYE MOVEMENT DISORDER 3 0.0004
306 LUMBAR VERTEBRAL FRACTURE 2 0.0004
307 ONYCHOCLASIS 3 0.0004
308 UROSEPSIS 4 0.0004
309 BLOOD POTASSIUM DECREASED 13 0.0004
310 ERYTHEMA MULTIFORME 4 0.0004
311 FEELING OF DESPAIR 2 0.0004
312 HALLUCINATION, VISUAL 9 0.0004
313 MUCOSAL INFLAMMATION 11 0.0004
314 NEUTROPENIC SEPSIS 3 0.0004
315 IRRITABLE BOWEL SYNDROME 9 0.0004
316 MYOCLONUS 5 0.0004
317 NEUROPATHY PERIPHERAL 39 0.0004
318 SMALL INTESTINAL OBSTRUCTION 5 0.0004
319 NIGHTMARE 14 0.0004
320 ORTHOSTATIC HYPOTENSION 7 0.0004
321 ANEURYSM 2 0.0004
322 PNEUMONIA ASPIRATION 10 0.0004
323 DERMATITIS EXFOLIATIVE 2 0.0004
324 SECRETION DISCHARGE 5 0.0004
325 LYMPHOCYTE COUNT DECREASED 7 0.0004
326 INSURANCE ISSUE 6 0.0004
327 ABDOMINAL INFECTION 1 0.0004
328 RIB FRACTURE 8 0.0004
329 BLOOD CHLORIDE DECREASED 1 0.0004
330 ACUTE LYMPHOCYTIC LEUKAEMIA RECURRENT 1 0.0004
331 PELVIC FRACTURE 3 0.0004
332 BRAIN FOG 6 0.0004
333 TORSADE DE POINTES 3 0.0004
334 PRODUCT ADMINISTRATION INTERRUPTED 3 0.0004
335 FALL 127 0.0004
336 LIVER FUNCTION TEST ABNORMAL 11 0.0004
337 CYSTITIS 12 0.0004
338 DELIRIUM 13 0.0004
339 ABDOMINAL RIGIDITY 1 0.0004
340 BLOOD PHOSPHORUS INCREASED 1 0.0004
341 NONSPECIFIC REACTION 2 0.0004
342 UPPER-AIRWAY COUGH SYNDROME 3 0.0004
343 ABDOMINAL DISTENSION 38 0.0004
344 ASTHENOPIA 2 0.0004
345 URINARY TRACT INFECTION 62 0.0004
346 SPINAL COMPRESSION FRACTURE 3 0.0004
347 HYPERKERATOSIS 2 0.0004
348 GASTRIC ULCER HAEMORRHAGE 2 0.0004
349 HOT FLUSH 27 0.0004
350 ANAL HAEMORRHAGE 1 0.0004
351 PRODUCT LEAKAGE 2 0.0004
352 CHOLECYSTITIS ACUTE 2 0.0004
353 FACIAL PARALYSIS 3 0.0004
354 VITAMIN D DECREASED 3 0.0004
355 INTERNATIONAL NORMALISED RATIO INCREASED 10 0.0004
356 SCAB 4 0.0004
357 BLOOD CREATINE PHOSPHOKINASE INCREASED 10 0.0003
358 PYELONEPHRITIS 3 0.0003
359 DYSKINESIA 14 0.0003
360 DEVICE USE ISSUE 6 0.0003
361 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 3 0.0003
362 BRADYKINESIA 2 0.0003
363 COVID-19 PNEUMONIA 4 0.0003
364 BLOOD CULTURE POSITIVE 1 0.0003
365 LOSS OF LIBIDO 3 0.0003
366 TYPE 1 DIABETES MELLITUS 2 0.0003
367 C-REACTIVE PROTEIN INCREASED 12 0.0003
368 DEPRESSED LEVEL OF CONSCIOUSNESS 13 0.0003
369 BRAIN NATRIURETIC PEPTIDE INCREASED 1 0.0003
370 PRESCRIPTION DRUG USED WITHOUT A PRESCRIPTION 2 0.0003
371 LIMB DISCOMFORT 10 0.0003
372 ILEUS 4 0.0003
373 BLOOD BLISTER 1 0.0003
374 PRODUCT DOSE OMISSION IN ERROR 9 0.0003
375 PRODUCT USE COMPLAINT 5 0.0003
376 HAEMATEMESIS 8 0.0003
377 CONFUSIONAL STATE 51 0.0003
378 BLADDER PAIN 1 0.0003
379 HYPERSOMNIA 9 0.0003
380 OBESITY 5 0.0003
381 ROTATOR CUFF SYNDROME 4 0.0003
382 INFUSION SITE PAIN 4 0.0003
383 BACK DISORDER 5 0.0003
384 AMNESIA 20 0.0003
385 SKIN FISSURES 6 0.0003
386 PHARYNGEAL SWELLING 3 0.0003
387 MEDICATION ERROR 17 0.0003
388 RENAL TUBULAR NECROSIS 3 0.0003
389 HALLUCINATION 23 0.0003
390 SOMNAMBULISM 2 0.0003
391 SINUS DISORDER 6 0.0003
392 ARTERIOSCLEROSIS CORONARY ARTERY 2 0.0003
393 ADVERSE REACTION 4 0.0003
394 COGNITIVE DISORDER 14 0.0003
395 SKIN MASS 2 0.0003
396 PRODUCT ADMINISTRATION ERROR 6 0.0003
397 BRONCHIECTASIS 2 0.0003
398 LETHARGY 17 0.0003
399 AUTOIMMUNE HAEMOLYTIC ANAEMIA 1 0.0003
400 BLOOD PRESSURE FLUCTUATION 7 0.0003
401 CONTUSION 28 0.0003
402 APLASIA PURE RED CELL 1 0.0003
403 JOINT EFFUSION 2 0.0003
404 DROOLING 2 0.0003
405 MENTAL STATUS CHANGES 8 0.0003
406 LARGE INTESTINE PERFORATION 2 0.0003
407 APHONIA 4 0.0003
408 EXTRASYSTOLES 2 0.0003
409 CAROTID ARTERY STENOSIS 1 0.0003
410 HEAD INJURY 9 0.0003
411 DEVICE OCCLUSION 4 0.0003
412 DUODENAL ULCER 2 0.0003
413 DIVERTICULUM 2 0.0003
414 DRY EYE 14 0.0003
415 POOR QUALITY SLEEP 6 0.0003
416 HYPERGLYCAEMIA 10 0.0003
417 ASTHMATIC CRISIS 1 0.0003
418 MELAENA 6 0.0003
419 ACUTE MYOCARDIAL INFARCTION 8 0.0003
420 AMYLASE INCREASED 1 0.0003
421 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 13 0.0003
422 DRUG EFFECT LESS THAN EXPECTED 4 0.0003
423 HYPERTENSIVE CRISIS 3 0.0003
424 CATARACT 16 0.0003
425 MALNUTRITION 3 0.0003
426 OCULAR DISCOMFORT 3 0.0003
427 DEPRESSED MOOD 14 0.0003
428 CONTRAINDICATED PRODUCT ADMINISTERED 8 0.0003
429 TENDON PAIN 2 0.0003
430 DEPRESSION 60 0.0003
431 MUSCULOSKELETAL DISORDER 5 0.0003
432 SHOCK 6 0.0003
433 PULMONARY FIBROSIS 5 0.0003
434 JAUNDICE 7 0.0003
435 ATRIOVENTRICULAR BLOCK 2 0.0003
436 POST PROCEDURAL HAEMORRHAGE 3 0.0003
437 RENAL DISORDER 12 0.0003
438 HYPOALBUMINAEMIA 2 0.0003
439 CARDIOPULMONARY FAILURE 1 0.0003
440 MUSCULAR WEAKNESS 29 0.0003
441 AFFECTIVE DISORDER 2 0.0003
442 FURUNCLE 2 0.0003
443 BLOOD ALBUMIN DECREASED 2 0.0003
444 RENAL CYST 2 0.0003
445 GINGIVAL PAIN 2 0.0003
446 SCIATICA 4 0.0003
447 MUSCLE RIGIDITY 3 0.0003
448 AZOTAEMIA 1 0.0003
449 ELECTROCARDIOGRAM QT PROLONGED 9 0.0002
450 SPINAL FRACTURE 5 0.0002
451 SENSORY DISTURBANCE 4 0.0002
452 ACUTE KIDNEY INJURY 38 0.0002
453 VISION BLURRED 34 0.0002
454 ADRENAL INSUFFICIENCY 3 0.0002
455 SCHIZOPHRENIA 3 0.0002
456 BLOOD POTASSIUM INCREASED 4 0.0002
457 POST PROCEDURAL INFECTION 2 0.0002
458 DRUG INTERACTION 39 0.0002
459 RED BLOOD CELL COUNT DECREASED 7 0.0002
460 MUSCLE SPASTICITY 3 0.0002
461 ABNORMAL FAECES 2 0.0002
462 ARTHRITIS BACTERIAL 1 0.0002
463 AORTIC DISSECTION 1 0.0002
464 RHABDOMYOLYSIS 10 0.0002
465 UPPER GASTROINTESTINAL HAEMORRHAGE 4 0.0002
466 INFUSION SITE ERYTHEMA 2 0.0002
467 FACE OEDEMA 4 0.0002
468 MUSCLE ATROPHY 3 0.0002
469 DIZZINESS 118 0.0002
470 HEMIPARESIS 4 0.0002
471 AORTIC VALVE INCOMPETENCE 1 0.0002
472 CIRCULATORY COLLAPSE 4 0.0002
473 CARDIAC FAILURE CHRONIC 1 0.0002
474 PSEUDOMONAS INFECTION 2 0.0002
475 ILLNESS 24 0.0002
476 ANURIA 2 0.0002
477 BLOOD MAGNESIUM DECREASED 2 0.0002
478 CARDIAC MURMUR 2 0.0002
479 ALTERED STATE OF CONSCIOUSNESS 5 0.0002
480 MULTIPLE SCLEROSIS 11 0.0002
481 ORAL CANDIDIASIS 3 0.0002
482 GROIN PAIN 2 0.0002
483 SPINAL OSTEOARTHRITIS 2 0.0002
484 IMMUNE SYSTEM DISORDER 3 0.0002
485 DISORIENTATION 9 0.0002
486 SOPOR 3 0.0002
487 MYOSITIS 2 0.0002
488 MOBILITY DECREASED 16 0.0002
489 PANCREATITIS ACUTE 5 0.0002
490 PRODUCT DOSE OMISSION ISSUE 65 0.0002
491 OPTIC NEURITIS 2 0.0002
492 MOOD ALTERED 6 0.0002
493 LOSS OF CONSCIOUSNESS 28 0.0002
494 MEMORY IMPAIRMENT 30 0.0002
495 NEPHROLITHIASIS 10 0.0002
496 INCREASED TENDENCY TO BRUISE 2 0.0002
497 ABNORMAL DREAMS 6 0.0002
498 PRODUCT DISTRIBUTION ISSUE 2 0.0002
499 HYPOMAGNESAEMIA 3 0.0002
500 HUNGER 3 0.0002
501 MALAISE 94 0.0002
502 RENAL IMPAIRMENT 18 0.0002
503 MIDDLE INSOMNIA 4 0.0002
504 OXYGEN SATURATION DECREASED 12 0.0002
505 BLOOD TEST ABNORMAL 3 0.0002
506 TARDIVE DYSKINESIA 6 0.0002
507 DYSPNOEA EXERTIONAL 8 0.0002
508 STAPHYLOCOCCAL INFECTION 7 0.0002
509 SPUTUM DISCOLOURED 2 0.0002
510 WHITE BLOOD CELL COUNT INCREASED 8 0.0002
511 ATRIAL FIBRILLATION 20 0.0002
512 ORAL HERPES 4 0.0002
513 ASCITES 6 0.0002
514 INJECTION SITE URTICARIA 5 0.0002
515 VITREOUS FLOATERS 2 0.0002
516 OEDEMA 11 0.0002
517 DEHYDRATION 27 0.0002
518 RASH MACULAR 7 0.0002
519 DYSPHAGIA 19 0.0002
520 HYPERKALAEMIA 7 0.0002
521 FULL BLOOD COUNT DECREASED 4 0.0002
522 TOXIC EPIDERMAL NECROLYSIS 3 0.0002
523 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 1 0.0002
524 DISCOMFORT 12 0.0002
525 DRUG DISPENSING ERROR 3 0.0002
526 COUGH 55 0.0002
527 SLUGGISHNESS 2 0.0002
528 AMMONIA INCREASED 1 0.0002
529 CACHEXIA 1 0.0002
530 TEMPERATURE INTOLERANCE 2 0.0002
531 TENDONITIS 3 0.0002
532 POOR VENOUS ACCESS 2 0.0002
533 DELUSION 3 0.0002
534 DYSPEPSIA 19 0.0002
535 VENTRICULAR EXTRASYSTOLES 2 0.0002
536 THERAPY PARTIAL RESPONDER 3 0.0002
537 SWOLLEN TONGUE 6 0.0002
538 RESPIRATORY TRACT INFECTION 5 0.0002
539 TENDERNESS 2 0.0002
540 WEIGHT FLUCTUATION 2 0.0002
541 TRANSFUSION 2 0.0002
542 SYNCOPE 19 0.0002
543 INCONTINENCE 2 0.0002
544 SOMNOLENCE 38 0.0002
545 OSTEOARTHRITIS 8 0.0002
546 EYE SWELLING 7 0.0002
547 ABSCESS 3 0.0002
548 HYPOACUSIS 8 0.0002
549 BEHAVIOUR DISORDER 1 0.0002
550 PHARYNGITIS STREPTOCOCCAL 2 0.0002
551 RASH PRURITIC 10 0.0002
552 SKIN LACERATION 2 0.0002
553 PULMONARY THROMBOSIS 2 0.0002
554 TREATMENT NONCOMPLIANCE 10 0.0002
555 WOUND INFECTION 2 0.0002
556 ASPIRATION 2 0.0002
557 BLOOD GLUCOSE FLUCTUATION 2 0.0002
558 RED BLOOD CELL SEDIMENTATION RATE INCREASED 2 0.0002
559 ABDOMINAL PAIN 42 0.0002
560 STEVENS-JOHNSON SYNDROME 4 0.0002
561 FATIGUE 140 0.0002
562 BLOOD UREA INCREASED 3 0.0002
563 SKIN INFECTION 2 0.0002
564 NEPHROPATHY TOXIC 2 0.0002
565 TRANSIENT ISCHAEMIC ATTACK 6 0.0002
566 VISUAL IMPAIRMENT 22 0.0002
567 ANGER 6 0.0002
568 CHROMATURIA 4 0.0002
569 MYALGIA 30 0.0002
570 SINUSITIS 18 0.0002
571 BRONCHITIS 13 0.0002
572 DERMATITIS CONTACT 2 0.0002
573 HAEMATURIA 6 0.0002
574 INTERNAL HAEMORRHAGE 2 0.0002
575 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 3 0.0002
576 MYOCARDITIS 2 0.0002
577 GASTROOESOPHAGEAL REFLUX DISEASE 14 0.0002
578 GASTRIC HAEMORRHAGE 2 0.0002
579 MULTI-ORGAN FAILURE 3 0.0002
580 HYPOKALAEMIA 8 0.0002
581 BLOOD URIC ACID INCREASED 1 0.0002
582 UPPER RESPIRATORY TRACT INFECTION 8 0.0002
583 UNINTENTIONAL MEDICAL DEVICE REMOVAL 2 0.0002
584 OEDEMA PERIPHERAL 21 0.0002
585 INTENTIONAL PRODUCT MISUSE 15 0.0002
586 NEUROTOXICITY 3 0.0002
587 HEART RATE DECREASED 6 0.0002
588 SEPSIS 19 0.0002
589 COLD SWEAT 3 0.0002
590 PSYCHOTIC DISORDER 5 0.0002
591 DRUG ERUPTION 3 0.0002
592 PERIPHERAL SWELLING 26 0.0002
593 NEUROLEPTIC MALIGNANT SYNDROME 2 0.0002
594 OCULAR HYPERAEMIA 8 0.0002
595 ASTHMA 19 0.0002
596 DECREASED APPETITE 39 0.0002
597 BACK PAIN 39 0.0002
598 MACULAR DEGENERATION 2 0.0002
599 GOUT 3 0.0002
600 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 30 0.0002
601 BLOOD PRESSURE INADEQUATELY CONTROLLED 1 0.0002
602 APHASIA 5 0.0002
603 RESTLESS LEGS SYNDROME 3 0.0002
604 VERTIGO 10 0.0002
605 INJECTION SITE BRUISING 13 0.0002
606 ANAEMIA 31 0.0002
607 ABNORMAL WEIGHT GAIN 2 0.0002
608 PYREXIA 56 0.0002
609 HEPATIC ENZYME INCREASED 11 0.0002
610 PHARYNGITIS 2 0.0002
611 CYST 2 0.0002
612 BLOOD ALKALINE PHOSPHATASE INCREASED 4 0.0002
613 MULTIPLE SCLEROSIS RELAPSE 11 0.0002
614 LEUKOPENIA 8 0.0002
615 PLATELET COUNT DECREASED 17 0.0002
616 FRACTURE 3 0.0002
617 LIVER DISORDER 7 0.0002
618 HERPES ZOSTER 9 0.0002
619 HYPOTHYROIDISM 5 0.0002
620 INTRAOCULAR PRESSURE INCREASED 2 0.0002
621 HYPOPHAGIA 4 0.0002
622 EYE IRRITATION 9 0.0002
623 POST PROCEDURAL COMPLICATION 3 0.0002
624 ACUTE RESPIRATORY FAILURE 3 0.0002
625 SLEEP DISORDER 11 0.0002
626 ERECTILE DYSFUNCTION 4 0.0002
627 HIP FRACTURE 5 0.0002
628 HERNIA 3 0.0002
629 ERUCTATION 3 0.0002
630 SKIN ULCER 4 0.0002
631 CARDIAC FLUTTER 1 0.0002
632 RASH GENERALISED 4 0.0002
633 HIATUS HERNIA 2 0.0002
634 SKIN EXFOLIATION 13 0.0002
635 LOWER RESPIRATORY TRACT INFECTION 7 0.0002
636 ANGINA UNSTABLE 1 0.0002
637 SWELLING FACE 10 0.0002
638 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 8 0.0002
639 CHOLELITHIASIS 5 0.0002
640 TINNITUS 7 0.0002
641 CONDITION AGGRAVATED 46 0.0002
642 HAEMATOCRIT DECREASED 3 0.0002
643 BLOOD PRESSURE ABNORMAL 3 0.0002
644 UPPER LIMB FRACTURE 3 0.0002
645 PRESCRIBED UNDERDOSE 3 0.0002
646 EAR INFECTION 4 0.0002
647 LIP SWELLING 5 0.0001
648 CARDIAC FAILURE ACUTE 1 0.0001
649 GAIT INABILITY 5 0.0001
650 QUALITY OF LIFE DECREASED 2 0.0001
651 SINUS CONGESTION 2 0.0001
652 LIMB INJURY 4 0.0001
653 ABNORMAL LOSS OF WEIGHT 1 0.0001
654 LUNG NEOPLASM MALIGNANT 6 0.0001
655 INFLUENZA LIKE ILLNESS 12 0.0001
656 CENTRAL NERVOUS SYSTEM LESION 2 0.0001
657 PROSTATIC SPECIFIC ANTIGEN INCREASED 2 0.0001
658 RESPIRATORY ARREST 4 0.0001
659 ADVERSE DRUG REACTION 13 0.0001
660 TREMOR 24 0.0001
661 INTERSTITIAL LUNG DISEASE 7 0.0001
662 PULMONARY HYPERTENSION 3 0.0001
663 HAEMOPTYSIS 4 0.0001
664 WEIGHT INCREASED 32 0.0001
665 COVID-19 25 0.0001
666 KNEE ARTHROPLASTY 3 0.0001
667 DISSEMINATED INTRAVASCULAR COAGULATION 2 0.0001
668 SUICIDAL IDEATION 13 0.0001
669 FEELING ABNORMAL 34 0.0001
670 NASOPHARYNGITIS 26 0.0001
671 DIARRHOEA 91 0.0001
672 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 10 0.0001
673 HYPOAESTHESIA 21 0.0001
674 IMPAIRED QUALITY OF LIFE 2 0.0001
675 PARAESTHESIA ORAL 2 0.0001
676 ASTHENIA 52 0.0001
677 SEPTIC SHOCK 6 0.0001
678 COMPLICATION ASSOCIATED WITH DEVICE 2 0.0001
679 ABDOMINAL DISCOMFORT 23 0.0001
680 APATHY 2 0.0001
681 GASTROENTERITIS 2 0.0001
682 DYSSTASIA 4 0.0001
683 INFLAMMATION 7 0.0001
684 LABORATORY TEST ABNORMAL 4 0.0001
685 BLOOD PRESSURE DIASTOLIC DECREASED 1 0.0001
686 GAMMA-GLUTAMYLTRANSFERASE INCREASED 3 0.0001
687 ARTHROPOD BITE 1 0.0001
688 SKIN HAEMORRHAGE 2 0.0001
689 PULMONARY MASS 2 0.0001
690 HEADACHE 84 0.0001
691 HEPATIC FUNCTION ABNORMAL 5 0.0001
692 HAEMORRHAGE INTRACRANIAL 2 0.0001
693 RESPIRATORY DISORDER 4 0.0001
694 PNEUMONIA 43 0.0001
695 PRURITUS 51 0.0001
696 INTESTINAL OBSTRUCTION 5 0.0001
697 CORONARY ARTERY DISEASE 4 0.0001
698 BRADYCARDIA 7 0.0001
699 ECONOMIC PROBLEM 2 0.0001
700 HYPERHIDROSIS 17 0.0001
701 THERAPEUTIC RESPONSE DECREASED 8 0.0001
702 AORTIC ANEURYSM 1 0.0001
703 ABDOMINAL PAIN UPPER 27 0.0001
704 EPILEPSY 4 0.0001
705 ACIDOSIS 1 0.0001
706 BLOOD PRESSURE INCREASED 20 0.0001
707 DEVICE RELATED INFECTION 2 0.0001
708 VOMITING 61 0.0001
709 EMOTIONAL DISORDER 4 0.0001
710 GENERAL PHYSICAL HEALTH DETERIORATION 15 0.0001
711 MUSCULOSKELETAL CHEST PAIN 2 0.0001
712 PRODUCT USE IN UNAPPROVED INDICATION 32 0.0001
713 EJECTION FRACTION DECREASED 2 0.0001
714 ACUTE MYELOID LEUKAEMIA 2 0.0001
715 BASAL CELL CARCINOMA 2 0.0001
716 ARTERIAL OCCLUSIVE DISEASE 1 0.0001
717 CYANOSIS 2 0.0001
718 ARTHRITIS 10 0.0001
719 PNEUMOTHORAX 2 0.0001
720 HALLUCINATION, AUDITORY 2 0.0001
721 PRODUCTIVE COUGH 6 0.0001
722 MOOD SWINGS 4 0.0001
723 NECK PAIN 7 0.0001
724 PANCYTOPENIA 7 0.0001
725 BLOOD DISORDER 1 0.0001
726 BLISTER 7 0.0001
727 RHINORRHOEA 8 0.0001
728 DYSPNOEA 70 0.0001
729 MUSCLE TIGHTNESS 2 0.0001
730 NEUTROPHIL COUNT DECREASED 5 0.0001
731 AGITATION 9 0.0001
732 ASPHYXIA 1 0.0001
733 CONVULSION 7 0.0001
734 LIVER INJURY 3 0.0001
735 ENCEPHALOPATHY 3 0.0001
736 GENERALISED TONIC-CLONIC SEIZURE 2 0.0001
737 EXTRAPYRAMIDAL DISORDER 3 0.0001
738 ACUTE CORONARY SYNDROME 1 0.0001
739 BLOOD PRESSURE DECREASED 8 0.0001
740 SKIN DISORDER 4 0.0001
741 BLADDER CANCER 7 0.0001
742 CHEST PAIN 22 0.0001
743 ABDOMINAL PAIN LOWER 3 0.0001
744 CANDIDA INFECTION 2 0.0001
745 FLUSHING 12 0.0001
746 RENAL FAILURE ACUTE 5 0.0001
747 UNRESPONSIVE TO STIMULI 3 0.0001
748 HAEMATOMA 3 0.0001
749 MIGRAINE 11 0.0001
750 NEOPLASM PROGRESSION 4 0.0001
751 LOCAL SWELLING 2 0.0001
752 FEELING HOT 7 0.0001
753 GASTRITIS 3 0.0001
754 HYPOXIA 4 0.0001
755 BLOOD TRIGLYCERIDES INCREASED 2 0.0001
756 ANGIOEDEMA 5 0.0001
757 LYMPHADENOPATHY 4 0.0001
758 DIABETES MELLITUS INADEQUATE CONTROL 2 0.0001
759 TOXICITY TO VARIOUS AGENTS 19 0.0001
760 DRY SKIN 15 0.0001
761 CARDIAC FAILURE 9 0.0001
762 THERAPY INTERRUPTED 8 0.0001
763 WEIGHT DECREASED 31 0.0001
764 THROAT TIGHTNESS 3 0.0001
765 WHITE BLOOD CELL COUNT DECREASED 12 0.0001
766 OSTEOMYELITIS 2 0.0001
767 CRYING 4 0.0001
768 RESPIRATORY FAILURE 8 0.0001
769 ACCIDENTAL OVERDOSE 4 0.0001
770 RESTLESSNESS 4 0.0001
771 NAUSEA 86 0.0001
772 BLOOD GLUCOSE ABNORMAL 2 0.0001
773 ARTHROPATHY 6 0.0001
774 GASTROINTESTINAL HAEMORRHAGE 9 0.0001
775 CHEST DISCOMFORT 11 0.0001
776 BLOOD CREATININE INCREASED 7 0.0001
777 HAEMOGLOBIN DECREASED 11 0.0001
778 APPENDICITIS 1 0.0001
779 EPISTAXIS 8 0.0001
780 SWELLING 10 0.0001
781 OVERDOSE 23 0.0001
782 HEPATIC CIRRHOSIS 2 0.0001
783 PHOTOPHOBIA 2 0.0001
784 CEREBROVASCULAR ACCIDENT 18 0.0001
785 ARTERIOSCLEROSIS 1 0.0001
786 RASH 46 0.0001
787 COLITIS 4 0.0001
788 PULMONARY EMBOLISM 10 0.0001
789 INTENTIONAL DOSE OMISSION 3 0.0001
790 INSOMNIA 28 0.0001
791 PRODUCT SUBSTITUTION ISSUE 6 0.0001
792 CHOLESTASIS 2 0.0001
793 SEROTONIN SYNDROME 2 0.0001
794 PANCREATIC CARCINOMA 3 0.0001
795 ATELECTASIS 1 0.0001
796 DYSTONIA 2 0.0001
797 EAR PAIN 2 0.0001
798 MUSCULOSKELETAL STIFFNESS 9 0.0001
799 AUTOIMMUNE DISORDER 1 0.0001
800 PAIN 63 0.0001
801 PLASMA CELL MYELOMA 4 0.0001
802 SURGERY 6 0.0001
803 ALOPECIA 20 0.0001
804 PAIN IN EXTREMITY 30 0.0001
805 DISABILITY 2 0.0001
806 ACTIVITIES OF DAILY LIVING IMPAIRED 2 0.0001
807 INCORRECT DOSE ADMINISTERED 23 0.0001
808 AGGRESSION 5 0.0001
809 CYTOKINE RELEASE SYNDROME 2 0.0001
810 HEPATIC FAILURE 3 0.0001
811 LACRIMATION INCREASED 3 0.0001
812 CELLULITIS 5 0.0001
813 FEEDING DISORDER 2 0.0001
814 TASTE DISORDER 2 0.0001
815 INJURY ASSOCIATED WITH DEVICE 2 0.0001
816 BLINDNESS 4 0.0001
817 BODY TEMPERATURE INCREASED 2 0.0001
818 THERAPY CESSATION 5 0.0001
819 HYPERSENSITIVITY 18 0.0001
820 TOOTH LOSS 2 0.0001
821 COMPLETED SUICIDE 8 0.0001
822 INTENTIONAL DRUG MISUSE 2 0.0001
823 HAEMORRHAGE 10 0.0001
824 DRUG-INDUCED LIVER INJURY 3 0.0001
825 PARAESTHESIA 15 0.0001
826 HYPERTENSION 20 0.0001
827 PALPITATIONS 11 0.0001
828 METABOLIC ACIDOSIS 3 0.0001
829 RETCHING 2 0.0001
830 BREAST PAIN 1 0.0001
831 MOVEMENT DISORDER 3 0.0001
832 LIVER FUNCTION TEST INCREASED 2 0.0001
833 BREAST CANCER METASTATIC 1 0.0001
834 RECTAL HAEMORRHAGE 4 0.0001
835 NIGHT SWEATS 3 0.0001
836 DISTURBANCE IN ATTENTION 5 0.0001
837 MUSCLE SPASMS 17 0.0001
838 LACTIC ACIDOSIS 3 0.0001
839 DEEP VEIN THROMBOSIS 6 0.0001
840 CHRONIC KIDNEY DISEASE 7 0.0001
841 BIPOLAR DISORDER 1 0.0001
842 BACK INJURY 1 0.0001
843 DIABETES MELLITUS 7 0.0001
844 CLOSTRIDIUM DIFFICILE INFECTION 2 0.0001
845 EYE DISORDER 3 0.0001
846 FEBRILE NEUTROPENIA 6 0.0001
847 FUNGAL INFECTION 3 0.0001
848 TOOTH DISORDER 2 0.0001
849 COLITIS ULCERATIVE 4 0.0001
850 GASTROINTESTINAL DISORDER 8 0.0001
851 EYE PRURITUS 3 0.0001
852 DEVICE ISSUE 8 0.0001
853 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 18 0.0001
854 OFF LABEL USE 77 0.0001
855 GASTRIC DISORDER 3 0.0001
856 ARTHRALGIA 36 0.0001
857 BLOOD CHOLESTEROL INCREASED 4 0.0001
858 PRODUCT USE ISSUE 16 0.0001
859 NASAL CONGESTION 5 0.0001
860 TREATMENT FAILURE 7 0.0001
861 ARRHYTHMIA 4 0.0001
862 WHEEZING 5 0.0001
863 BLOOD IRON DECREASED 1 0.0001
864 DISEASE RECURRENCE 4 0.0001
865 PRODUCT PRESCRIBING ERROR 2 0.0001
866 CEREBRAL HAEMORRHAGE 3 0.0001
867 IRRITABILITY 5 0.0001
868 RENAL FAILURE 11 0.0001
869 LOCALISED INFECTION 2 0.0001
870 HYPOGLYCAEMIA 4 0.0001
871 STOMATITIS 5 0.0001
872 BURSITIS 1 0.0001
873 PLEURAL EFFUSION 5 0.0001
874 CEREBRAL INFARCTION 2 0.0001
875 ALANINE AMINOTRANSFERASE INCREASED 5 0.0001
876 CARDIOMEGALY 1 0.0001
877 ABASIA 2 0.0001
878 DYSGEUSIA 6 0.0001
879 INFLUENZA 9 0.0001
880 INTENTIONAL PRODUCT USE ISSUE 7 0.0001
881 GLYCOSYLATED HAEMOGLOBIN INCREASED 2 0.0001
882 TACHYCARDIA 7 0.0001
883 FLUID RETENTION 4 0.0001
884 ERYTHEMA 16 0.0001
885 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 2 0.0001
886 ANAPHYLACTIC SHOCK 2 0.0001
887 EXPOSURE VIA SKIN CONTACT 2 0.0001
888 CHILLS 9 0.0001
889 NERVOUSNESS 4 0.0001
890 DEAFNESS 2 0.0001
891 ECZEMA 4 0.0001
892 SEDATION 2 0.0001
893 JOINT STIFFNESS 2 0.0001
894 BEDRIDDEN 1 0.0001
895 DERMATITIS ATOPIC 4 0.0001
896 ABNORMAL BEHAVIOUR 3 0.0001
897 PANCREATITIS 4 0.0001
898 ASPARTATE AMINOTRANSFERASE INCREASED 4 0.0001
899 BREAST CANCER FEMALE 2 0.0001
900 CARDIAC DISORDER 7 0.0001
901 THROMBOSIS 6 0.0001
902 BLOOD GLUCOSE INCREASED 14 0.0001
903 ANXIETY 21 0.0001
904 DRUG INEFFECTIVE 96 0.0001
905 CARDIAC ARREST 6 0.0001
906 RESPIRATORY DISTRESS 2 0.0001
907 ANAPHYLACTIC REACTION 4 0.0001
908 DIVERTICULITIS 2 0.0001
909 PROCEDURAL PAIN 2 0.0001
910 URTICARIA 12 0.0001
911 HOSPITALISATION 11 0.0001
912 WOUND 2 0.0001
913 THROMBOCYTOPENIA 8 0.0001
914 FLATULENCE 4 0.0001
915 ANOSMIA 1 0.0001
916 CARDIOMYOPATHY 1 0.0001
917 BONE LOSS 1 0.0001
918 JOINT SWELLING 8 0.0001
919 NEUTROPENIA 9 0.0001
920 BLOOD COUNT ABNORMAL 1 0.0001
921 SKIN DISCOLOURATION 3 0.0001
922 ADVERSE EVENT 6 0.0001
923 ANKLE FRACTURE 1 0.0001
924 FEMUR FRACTURE 2 0.0001
925 BLOOD LACTATE DEHYDROGENASE INCREASED 1 0.0001
926 COMA 3 0.0001
927 RASH ERYTHEMATOUS 3 0.0001
928 CARDIAC FAILURE CONGESTIVE 5 0.0001
929 PRODUCT DOSE OMISSION 4 0.0001
930 INFUSION RELATED REACTION 4 0.0001
931 THERAPEUTIC RESPONSE SHORTENED 2 0.0001
932 EXPIRED PRODUCT ADMINISTERED 2 0.0001
933 VIRAL INFECTION 2 0.0001
934 TYPE 2 DIABETES MELLITUS 2 0.0001
935 DEATH 50 0.0001
936 ACUTE RESPIRATORY DISTRESS SYNDROME 1 0.0001
937 INJECTION SITE ERYTHEMA 7 0.0001
938 DRUG EFFECT INCOMPLETE 2 0.0001
939 BONE DISORDER 1 0.0001
940 HAEMATOCHEZIA 3 0.0001
941 BACTERIAL INFECTION 1 0.0001
942 UNEVALUABLE EVENT 4 0.0001
943 INJECTION SITE SWELLING 4 0.0001
944 SEIZURE 6 0.0001
945 DRUG INTOLERANCE 5 0.0001
946 PROSTATE CANCER 4 0.0000
947 EMOTIONAL DISTRESS 6 0.0000
948 PSORIATIC ARTHROPATHY 2 0.0000
949 DEVICE BREAKAGE 2 0.0000
950 BONE MARROW FAILURE 1 0.0000
951 OSTEOPOROSIS 2 0.0000
952 INFECTION 7 0.0000
953 CARDIO-RESPIRATORY ARREST 2 0.0000
954 INTENTIONAL OVERDOSE 3 0.0000
955 DEVICE DISLOCATION 2 0.0000
956 MENTAL DISORDER 2 0.0000
957 PSORIASIS 6 0.0000
958 INJECTION SITE PAIN 14 0.0000
959 NEOPLASM MALIGNANT 3 0.0000
960 THERAPEUTIC PRODUCT EFFECT DECREASED 2 0.0000
961 THROAT IRRITATION 2 0.0000
962 THERAPY NON-RESPONDER 2 0.0000
963 SKIN IRRITATION 2 0.0000
964 OROPHARYNGEAL PAIN 4 0.0000
965 BREAST CANCER 4 0.0000
966 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 2 0.0000
967 BURNING SENSATION 3 0.0000
968 DISEASE PROGRESSION 5 0.0000
969 HEART RATE INCREASED 4 0.0000
970 AGEUSIA 1 0.0000
971 CARDIOVASCULAR DISORDER 1 0.0000
972 ANHEDONIA 1 0.0000
973 BLOOD BILIRUBIN INCREASED 1 0.0000
974 DRUG ABUSE 3 0.0000
975 RHEUMATOID ARTHRITIS 4 0.0000
976 ANGINA PECTORIS 1 0.0000
977 SUICIDE ATTEMPT 2 0.0000
978 BONE DENSITY DECREASED 1 0.0000
979 ACCIDENTAL EXPOSURE TO PRODUCT 3 0.0000
980 DEVICE MALFUNCTION 2 0.0000
981 INJURY 2 0.0000
982 SKIN BURNING SENSATION 2 0.0000
983 UNDERDOSE 2 0.0000
984 FOETAL EXPOSURE DURING PREGNANCY 2 0.0000
985 MYOCARDIAL INFARCTION 4 0.0000
986 PRODUCT STORAGE ERROR 2 0.0000
987 NO ADVERSE EVENT 4 0.0000
988 ACNE 1 0.0000